SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001193125-24-019734
Filing Date
2024-01-31
Accepted
2024-01-30 18:54:27
Documents
10

Document Format Files

Seq Description Document Type Size
1 F-1 d709814df1.htm F-1 374391
2 EX-3.1 d709814dex31.htm EX-3.1 527325
3 EX-5.1 d709814dex51.htm EX-5.1 49202
4 EX-23.1 d709814dex231.htm EX-23.1 2249
5 EX-23.2 d709814dex232.htm EX-23.2 1715
6 EX-FILING FEES d709814dexfilingfees.htm EX-FILING FEES 25790
7 GRAPHIC g709814g0126101546809.jpg GRAPHIC 3113
8 GRAPHIC g709814g0126101546921.jpg GRAPHIC 7569
9 GRAPHIC g709814g0129125509789.jpg GRAPHIC 3790
10 GRAPHIC g709814g79x61.jpg GRAPHIC 68195
  Complete submission text file 0001193125-24-019734.txt   1096362
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: F-1 | Act: 33 | File No.: 333-276774 | Film No.: 24580071
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)